12:00 AM
May 24, 1999
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Declopramide: Phase I data; Phase I/II

OXGN reported interim safety data from two ongoing dose-ranging studies of declopramide plus cisplatin or 5-fluorouracil (5-FU) in patients with advanced cancers. In the 10-patient cisplatin trial, clinicians saw transient...

Read the full 129 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >